ACUTE RESPIRATORY DISTRESS SYNDROME SECONDARY TO INFLUENZA A(H1N1)PDM09: CLINICAL CHARACTERISTICS AND MORTALITY PREDICTORS

被引:0
|
作者
Margarita Hernandez-Cardenas, Carmen [1 ]
Serna-Secundino, Hector [1 ]
Guadalupe Garcia-Olazaran, Jose [1 ]
Leticia Aguilar-Perez, Cristina [1 ]
Rocha-Machado, Jesus [1 ]
Fernando Campos-Calderon, Luis [1 ]
Lugo-Goytia, Gustavo [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Resp Intens Care Unit, Calzada Tlalpan,4502 Col Secc 16, Mexico City 14080, DF, Mexico
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2016年 / 68卷 / 05期
关键词
ARDS; Influenza A(H1N1)pdm09; Mortality; Prognostic factors; 2013-2014 influenza season; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; PANDEMIC INFLUENZA; A H1N1; VIRUS-INFECTION; A/H1N1; INFLUENZA; MEXICO; METAANALYSIS; PNEUMONIA; BACTERIAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute respiratory distress syndrome secondary to influenza A(H1N1)pdm09 virus is the leading cause of death among this patient population. Expanding the knowledge of its course and predictors of mortality is relevant to decision making. We aimed to describe the clinical characteristics and identify factors associated with mortality in patients with acute respiratory distress syndrome secondary to influenza A(H1N1)pdm09 during the 2013-2014 influenza season. Methods: This is an observational study of a prospective cohort of 70 patients with acute respiratory distress syndrome and influenza A(H1N1) pdm09 seen in an academic medical center. Multivariate logistic regression was used to identify the independent mortality predictors. Bootstrap was used for internal model validation. Results: This cohort was represented by young adults (43 +/- 11 years old). Obesity was present in 62.5% and was not associated with mortality. Mortality at 28 days and at discharge from the respiratory intensive care unit was 14 and 20%, respectively. All patients met the criteria for acute respiratory distress syndrome, 73% had vasodilatory shock, and 27.1% had acute kidney injury on respiratory intensive care unit admission. We observed a high incidence of intensive care unit-acquired weakness (81.4%). Ventilator-associated pneumonia developed in 47.1% and was not associated with mortality. In multivariate analysis, independent risk factors for intensive care unit mortality were age (odds ratio [OR] = 1.102), white blood cell count (OR = 1.22), and lactate dehydrogenase levels (OR = 1.004) on admission to the intensive care unit. Conclusions: We described the clinical characteristics and course of a cohort of patients with acute respiratory distress syndrome secondary to influenza A(H1N1)pdm09, and developed a predictive model of mortality based on the covariates age, levels of lactate dehydrogenase, and white cell count on admission to the respiratory intensive care unit.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [21] Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany
    Reuss, Annicka
    Dehnert, Manuel
    Buda, Silke
    Haas, Walter
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (06) : 1427 - 1432
  • [22] Behavioural response in educated young adults towards influenza A(H1N1)pdm09
    Chen, S. C.
    Hsieh, N. H.
    You, S. H.
    Wang, C. H.
    Liao, C. M.
    EPIDEMIOLOGY AND INFECTION, 2015, 143 (09) : 1846 - 1857
  • [23] Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study
    Khandaker, Gulam
    Zurynski, Yvonne
    Ridley, Greta
    Buttery, Jim
    Marshall, Helen
    Richmond, Peter C.
    Royle, Jenny
    Gold, Michael
    Walls, Tony
    Whitehead, Bruce
    McIntyre, Peter
    Wood, Nicholas
    Booy, Robert
    Elliott, Elizabeth J.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2014, 8 (06) : 636 - 645
  • [24] Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning
    Zelner, Jon
    Petrie, Joshua G.
    Trangucci, Rob
    Martin, Emily T.
    Monto, Arnold S.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (01) : 12 - 19
  • [25] Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09
    Louie, Janice K.
    Yang, Samuel
    Yen, Cynthia
    Acosta, Meileen
    Schechter, Robert
    Uyeki, Timothy M.
    PLOS ONE, 2012, 7 (06):
  • [26] Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
    Gefenaite, Giedre
    Tacken, Margot
    Bos, Jens
    Stirbu-Wagner, Irina
    Korevaar, Joke C.
    Stolk, Ronald P.
    Wolters, Bert
    Bijl, Marc
    Postma, Maarten J.
    Wilschut, Jan
    Nichol, Kristin L.
    Hak, Eelko
    PLOS ONE, 2013, 8 (06):
  • [27] Population dynamics at neuraminidase position 151 of influenza A (H1N1)pdm09 virus in clinical specimens
    Gong, Yu-Nong
    Tsao, Kuo-Chien
    Chen, Guang-Wu
    Wu, Chung-Jung
    Chen, Yi-Hsiang
    Liu, Yi-Chun
    Yang, Shu-Li
    Huang, Yhu-Chering
    Shih, Shin-Ru
    JOURNAL OF GENERAL VIROLOGY, 2019, 100 (05) : 752 - 759
  • [28] A study of an influenza A (H1N1)pdm09 outbreak in pregnant women in Rajasthan, India
    Agrawal, Abhishek
    Agarwal, Sujata
    Kumar, Vinay
    Nawal, Chuttan L.
    Mital, Pradeep
    Chejara, Radheyshyam
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 132 (02) : 146 - 150
  • [29] Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1) pdm09
    Louie, Janice K.
    Yang, Samuel
    Acosta, Meileen
    Yen, Cynthia
    Samuel, Michael C.
    Schechter, Robert
    Guevara, Hugo
    Uyeki, Timothy M.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (09) : 1198 - 1204
  • [30] Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
    Alvarez-Lerma, Francisco
    Marin-Corral, Judith
    Vila, Clara
    Ramon Masclans, Joan
    Gonzalez de Molina, Francisco Javier
    Martin Loeches, Ignacio
    Barbadillo, Sandra
    Rodriguez, Alejandro
    CRITICAL CARE, 2016, 20